Press Release Archives - Page 2 of 2

November 22, 2024October 20, 2025

Break Through Cancer Announces First Patient Enrolled in Phase 2 Trial Targeting Residual Disease in AML

News Release For Immediate Release Media Contact: Kari McHugh Kari.McHugh@breakthroughcancer.org Break Through Cancer Announces First Patient Enrolled in Phase 2 Trial Targeting Residual Disease in AML The novel study explores the effects of menin inhibition in acute myeloid leukemia with minimal residual disease as an endpoint. (CAMBRIDGE, MASS.) November 1, 2024 – Break Through Cancer, a Boston-based cancer research foundation, has launched a clinical trial to explore if an investigational drug can eliminate minimal residual disease (MRD) in acute myeloid leukemia (AML). AML often responds well to initial treatment, but residual cancer cells frequently cause relapse. Break Through Cancer’s......

September 26, 2024October 20, 2025

No More “Wait and See”: Two Clinical Trials Target the Origins of Recurrent Ovarian Cancer

News Release For Immediate Release Media Contact: Kari McHugh Kari.McHugh@breakthroughcancer.org No More “Wait and See”: Two Clinical Trials Target the Origins of Recurrent Ovarian Cancer Break Through Cancer scientists are evaluating a “second-look” technique to measure and destroy persistent cancer cells resistant to frontline chemotherapy. (CAMBRIDGE, MASS.) September 26, 2024 – After initial therapy to treat ovarian cancer, a small number of cancer cells, undetectable on scans, often linger in the body. These cells, referred to as minimal residual disease (MRD), are the seed from which cancer can and does recur for most women diagnosed with stage III or......

May 9, 2024October 20, 2025

Break Through Cancer and ALK Positive, Inc. Team Up to Conquer ALK-Positive Lung Cancer with a $2 Million, Multi-year, Research Partnership

News Release For Immediate Release Media Contact: Kari McHugh Kari.McHugh@breakthroughcancer.org Break Through Cancer and ALK Positive, Inc. Team Up to Conquer ALK-Positive Lung Cancer with a $2 Million, Multi-year, Research Partnership CAMBRIDGE, MA, May 9, 2024 /Break Through Cancer announces a new partnership with ALK Positive Inc. (ALK Positive), a foundation funded by patients with ALK-positive lung cancer and their families. ALK Positive and Break Through Cancer are joining forces to fund a new initiative in lung cancer research with the hope of creating durable responses and cures for patients with ALK-positive lung cancer. ALK Positive is the......

April 4, 2024October 10, 2025

Reimagining Cancer Team Science: Six Hallmarks of Cancer Collaboration

News Release For Immediate Release Media Contact: Kari McHugh KM@breakthroughcancer.org Reimagining Cancer Team Science: Six Hallmarks of Cancer Collaboration A new commentary in Cancer Discovery presents a playbook of best practices for cancer team science in the modern era. (CAMBRIDGE, MASS.) April 4, 2024 – The oncology community has a powerful opportunity to speed the creation of impactful new treatments by adopting a modern playbook for collaboration, according to scientists from Break Through Cancer and other team-oriented cancer organizations working together in a commentary in the journal Cancer Discovery Jesse Boehm and Tyler Jacks of Break Through Cancer, a......

November 5, 2023October 10, 2025

Break Through Cancer Summit Advances ‘Radical Collaboration’ Among Top Cancer Centers

Scientists and funders unite to tackle urgent projects across four deadly cancers at annual meeting. Carol Aghajanian, M.D., and other members of the Targeting Minimal Residual Disease in Ovarian Cancer TeamLab at the 2023 Break Through Cancer Summit (KIAWAH, SOUTH CAROLINA) November 5, 2023 -- Today, Break Through Cancer, a collaborative medical research foundation, welcomes over 120 scientists and physicians from five leading cancer centers, as well as representatives from ARPA-H, to its annual Summit, November 5th to 8th in Kiawah, South Carolina. The gathering arrives at an unprecedented moment for oncology, when breakthroughs in genomic technologies, machine learning, and novel......

May 16, 2023October 10, 2025

Break Through Cancer Launches Two TeamLabs Targeting Acute Myelogenous Leukemia (AML)

Break Through Cancer Launches Two TeamLabs Targeting Acute Myelogenous Leukemia (AML) Novel research program embracing radical collaboration to discover potential AML treatments (CAMBRIDGE, MASS.) MAY 16, 2023 – Break Through Cancer, a collaborative medical research organization empowering researchers and physicians from top cancer research institutions to intercept and find cures for several of the world’s deadliest cancers, is announcing the launch of the Targeting Clonal Hematopoiesis to Prevent AML TeamLab and the Eradicating Minimal Residual Disease in AML TeamLab. AML begins in the blood-forming cells of the bone marrow and rapidly moves into the bloodstream, where it can quickly spread......

April 24, 2023October 10, 2025

Break Through Cancer, A New Research Consortium, Names First Class of Scientists Designated as Catalysts for Innovation and Collaboration

Break Through Cancer, A New Research Consortium, Names First Class of Scientists Designated as Catalysts for Innovation and Collaboration Highly skilled professional scientists at partner institutes will spur development of novel approaches to understanding cancer and developing new treatment strategies (CAMBRIDGE, MASS.) APRIL 25, 2023 – Break Through Cancer, a foundation designed to find new solutions to some of the most intractable challenges in cancer, has named four individuals as Break Through Cancer Scientists—Neelkanth Bardhan, Sreyashi Basu, Paola A. Guerrero, and Thomas R. Pisanic II. They are professional scientists who cooperate on and lead projects with the skills, knowledge, and......

April 19, 2022March 16, 2023

MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers

MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers Funding is part of $50 million in grants to teams at five cancer centers charged to work together Contact: Clayton Boldt, Ph.D. Office: 713-792-9518 Cell: 409-673-5582 crboldt@mdanderson.org HOUSTON ― The University of Texas MD Anderson Cancer Center...

April 19, 2022October 10, 2025

Break Through Cancer Announces $50M in Grants to Empower Researchers from Five Top Cancer Research Centers to Work as One

Break Through Cancer Announces $50M in Grants to Empower Researchers from Five Top Cancer Research Centers to Work as One New cancer research foundation will help accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers using a bold new approach. CAMBRIDGE, Mass., April 19, 2022 – Today, one year after its founding, Break Through Cancer announced...

February 25, 2021October 10, 2025

Break Through Cancer Launches Collaborative Model

Break Through Cancer Launches Collaborative Model Across Top U.S. Research Institutions in Pursuit of Cancer Cures New foundation brings together teams from Dana-Farber Cancer Institute, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and the Koch Institute for Integrative Cancer Research...